July 27, 2026 · Form 4 insider transaction
Martin Christopher Nathan bought 16,700 shares of Achieve Life Sciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each RSU represents a contingent right to receive one share of the Issuer's common stock at settlement.; Pursuant to the terms of the RSU, the shares underlying the RSU vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date.